InflaRx to Showcase Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
JENA, Germany, Feb. 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company…
Vixichains DevNet goes live to provide banks secure and compliant access to DeFi
To complement its DevNet launch, Vixichain introduces a web-based version of the…
ZEELOOL: How to select glasses frames for your face?
Thursday 19 September, 2024 With a wide array of options to choose…
Maropost extends its “High Performer” streak in G2 Winter Reports while earning new “Easiest to Use” badge
Marketing Cloud reinforces mid-market excellence in marketing automation across seven categories and…
